The Patent Finder

Neupharma, Inc.

Also on record
Records under this name other than the patents Neupharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 35 patents it holds.

Showing 1 to 6 of 6 · Back to Neupharma, Inc.

PatentTitleStatus Expires Confidence
US 10,047,059Substituted Quinoxalines for Inhibiting Kinase Activity
Lapsed on the fee record
Ended Aug 14, 2026 · Medium confidence
Lapsed on the fee recordEnded Aug 14, 2026Medium confidence
US 8,691,977Certain chemical entities, compositions, and methods
Lapsed on the fee record
Ended Apr 8, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 8, 2026From the USPTO record
US 9,908,866Certain chemical entities, compositions, and methods
Lapsed on the fee record
Ended Mar 6, 2026 · From the USPTO record
Lapsed on the fee recordEnded Mar 6, 2026From the USPTO record
US 8,614,211Certain chemical entities, compositions, and methods
Lapsed on the fee record
Ended Dec 24, 2025 · From the USPTO record
Lapsed on the fee recordEnded Dec 24, 2025From the USPTO record
US 9,707,202Certain chemical entities, compositions, and methods
Lapsed on the fee record
Ended Jul 18, 2025 · From the USPTO record
Lapsed on the fee recordEnded Jul 18, 2025From the USPTO record
US 9,328,081Certain chemical entities, compositions, and methods
Lapsed on the fee record
Ended May 3, 2024 · From the USPTO record
Lapsed on the fee recordEnded May 3, 2024From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited